Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$105.17
+2.4%		$100.16
$43.07
▼
$118.46
$5.11B1.011.48 million shs1.09 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$146.69
+1.9%		$93.65
$22.28
▼
$176.66
$57.48B1.133.97 million shs10.55 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
+2.41%-2.24%-7.24%+43.54%+86.04%
Moderna, Inc. stock logo
MRNA
Moderna
+1.89%+0.78%+131.66%+164.78%+523.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$105.17
+2.4%		$100.16
$43.07
▼
$118.46
$5.11B1.011.48 million shs1.09 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$146.69
+1.9%		$93.65
$22.28
▼
$176.66
$57.48B1.133.97 million shs10.55 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
+2.41%-2.24%-7.24%+43.54%+86.04%
Moderna, Inc. stock logo
MRNA
Moderna
+1.89%+0.78%+131.66%+164.78%+523.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
2.28
Hold$83.47-20.64% Downside
Moderna, Inc. stock logo
MRNA
Moderna
2.08
Hold$76.72-47.70% Downside

Current Analyst Ratings Breakdown

Latest CAKE and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2026
Moderna, Inc. stock logo
MRNA
Moderna
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$81.00
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Sell
9/3/2026
Moderna, Inc. stock logo
MRNA
Moderna
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral ➝ Sell$40.00 ➝ $81.00
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
CLSA logo
CLSA
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageHold
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
Bradesco Corretora logo
Bradesco Corretora
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform
8/28/2026
Moderna, Inc. stock logo
MRNA
Moderna
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Buy$180.00
8/26/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$92.00 ➝ $105.00
8/25/2026
Moderna, Inc. stock logo
MRNA
Moderna
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeUnderperform ➝ Peer Perform
(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$3.88B1.35$6.00 per share17.53$8.76 per share12.01
Moderna, Inc. stock logo
MRNA
Moderna
$2.21B26.50N/AN/A$22.14 per share6.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$148.43M$3.6928.5020.911.684.61%43.97%6.18%10/27/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$7.99N/AN/AN/A-141.43%-28.30%-19.39%11/5/2026 (Estimated)

Latest CAKE and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2026Q2 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$2.03-$1.97+$0.06-$1.97$102.93 million$145.00 million
7/28/2026Q2 2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$1.18$1.44+$0.26$1.41$999.54 million$1.03 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
$1.201.14%+24.57%32.52%N/A
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest CAKE and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/23/2026
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
quarterly$0.301.06%8/11/20268/11/20268/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
1.08
0.59
0.52
Moderna, Inc. stock logo
MRNA
Moderna
0.09
2.29
2.18

Institutional Ownership

CompanyInstitutional Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
94.48%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
8.00%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Cheesecake Factory Incorporated stock logo
CAKE
Cheesecake Factory
48,40049.76 million45.78 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700399.24 million356.12 millionOptionable

Recent News About These Companies

Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
September 14 at 7:03 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/moderna-mrna-ascends-while-market-215005821.html
Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
September 14 at 6:50 PM  |  zacks.comhttps://www.zacks.com/stock/news/2989478/moderna-mrna-ascends-while-market-falls-some-facts-to-note?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_6v1-2989478
Moderna (NASDAQ:MRNA) CFO Sells $4,685,093.64 in Stock
September 14 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-moderna-nasdaq-mrna-cfo-sells-468509364-in-stock-2026-09-14/
Moderna's AI-Built Cancer Vaccine Clears Phase 3 With Merck
September 14 at 4:06 PM  |  pymnts.comhttps://www.pymnts.com/healthcare/2026/modernas-ai-built-cancer-vaccine-clears-phase-3-with-merck/?utm_source=snapi
Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 14 at 3:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4946081-moderna-inc-mrna-presents-at-morgan-stanley-24th-annual-global-healthcare-conference
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
September 14 at 2:03 PM  |  biospace.comB
Promising Biotech Stocks To Follow Today - September 14th
September 14 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-biotech-stocks-to-follow-today-september-14th-2026-09-14/
Moderna’s Cancer Vaccine Win Fuels Broad Push Across Tumor Types
September 14 at 11:01 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-modernas-cancer-vaccine-win-fuels-broad-push-across-tumor-types-2026-09-14/
Get ready for flu season: Florida pharmacies rolling out new mRNA vaccines and updated COVID shots
September 14 at 9:02 AM  |  sun-sentinel.comS
After a brief storm of political headwinds, mRNA is back with strong momentum
September 14 at 4:01 AM  |  biospace.comB
Top Biotech Stocks To Watch Today - September 13th
September 13 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-top-biotech-stocks-to-watch-today-september-13th-2026-09-13/
Moderna and Merck's Cancer Vaccine Passes Phase 3 Test
September 12 at 7:58 PM  |  labroots.comL
Promising Biotech Stocks To Keep An Eye On - September 12th
September 12 at 12:00 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-promising-biotech-stocks-to-keep-an-eye-on-september-12th-2026-09-12/
California State Teachers Retirement System Buys 27,274,128 Shares of Moderna, Inc. $MRNA
September 12 at 3:36 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-california-state-teachers-retirement-system-buys-27274128-shares-of-moderna-inc-mrna-2026-09-12/
How Cathie Wood's fund gave us a back door to Moderna's breakthrough
September 11, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/how-cathie-woods-fund-gave-us-a-back-door-to-modernas-breakthrough/ar-AA2c2Klx
Healthcare Stocks To Keep An Eye On - September 11th
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-healthcare-stocks-to-keep-an-eye-on-september-11th-2026-09-11/
Moderna (NASDAQ:MRNA) Shares Up 6.7% - Should You Buy?
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-moderna-nasdaq-mrna-shares-up-67-should-you-buy-2026-09-11/
Best Biotech Stocks To Watch Now - September 11th
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-best-biotech-stocks-to-watch-now-september-11th-2026-09-11/
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat
September 11, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/09/11/moderna-rallies-8-on-2026-melt-up-momentum-even-while-biontech-and-merck-stay-flat/?utm_source=snapi
Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-amundi-reduces-stock-holdings-in-moderna-inc-mrna-2026-09-11/
Rep. Maria Elvira Salazar Sells Moderna, Inc. (NASDAQ:MRNA) Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-rep-maria-elvira-salazar-sells-moderna-inc-nasdaq-mrna-stock-2026-09-11/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Illustration of a computer chip on a circuit board with an upward green stock chart line in a server room.
Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
By Thomas Hughes | August 31, 2026
Moderna logo displayed in a laboratory setting with a vaccine vial, petri dishes, and a microscope.
Moderna’s 177% Surge Has Investors Asking What Comes Next
By Sam Quirke | August 21, 2026
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
Cheesecake Factory stock logo

Cheesecake Factory NASDAQ:CAKE

$105.17 +2.47 (+2.41%)
Closing price 09/14/2026 04:00 PM Eastern
Extended Trading
$104.54 -0.64 (-0.60%)
As of 09/14/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Cheesecake Factory Incorporated operates and licenses restaurants in the United States and Canada. The company operates bakeries that produce cheesecakes and other baked products for its restaurants, international licensees, third-party bakery customers, external foodservice operators, retailers, and distributors. It operates restaurants under the brands comprising The Cheesecake Factory, North Italia, Flower Child, Fox Restaurant Concepts. The Cheesecake Factory Incorporated was founded in 1972 and is headquartered in Calabasas, California.

Moderna stock logo

Moderna NASDAQ:MRNA

$146.69 +2.72 (+1.89%)
Closing price 09/14/2026 04:00 PM Eastern
Extended Trading
$146.82 +0.13 (+0.09%)
As of 09/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas